|
Volumn 22, Issue 3, 2008, Pages 492-
|
A Novel Molecular Mechanism to Account for the Action of Resveratrol against Reperfusion Injury
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE;
ENZYME;
INTERCELLULAR ADHESION MOLECULE 1;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
MYELOPEROXIDASE;
PLACEBO;
REACTIVE OXYGEN METABOLITE;
RESVERATROL;
CLINICAL TRIAL;
DRUG MECHANISM;
ENDOTHELIUM INJURY;
ENZYME ACTIVITY;
HUMAN;
IMMUNOMODULATION;
IMMUNOPHARMACOLOGY;
ISCHEMIA;
LETTER;
MICROVASCULATURE;
MOLECULAR DYNAMICS;
NEUTROPHIL;
NEUTROPHIL CHEMOTAXIS;
OXIDATIVE STRESS;
PATHOGENESIS;
PRIORITY JOURNAL;
REPERFUSION INJURY;
VASCULAR ENDOTHELIUM;
ANIMALS;
DISEASE MODELS, ANIMAL;
DOWN-REGULATION;
ENDOTHELIUM, VASCULAR;
INTERCELLULAR ADHESION MOLECULE-1;
LUMBAR VERTEBRAE;
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;
NEUTROPHILS;
REPERFUSION INJURY;
STILBENES;
|
EID: 43049114517
PISSN: 08905096
EISSN: None
Source Type: Journal
DOI: 10.1016/j.avsg.2008.01.002 Document Type: Letter |
Times cited : (3)
|
References (8)
|